PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more
- Author
- American Medical Association
- Published
- Tue 19 Apr 2016
- Episode Link
- http://dx.doi.org/10.1001/jama.2015.14214
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 19, 2016 issue
